未登录

K

Ken-ichi Takayama

RIKEN

H指数:42

被引数:5,177

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Androgen receptor and osteoglycin gene expression predicting prognosis of metastatic prostate cancer

SCIENTIFIC REPORTS

IF3.9

2024-12-280

OAAI

Inhibition of PSF Activity Overcomes Resistance to Treatment in Cancers Harboring Mutant p53

MOLECULAR CANCER THERAPEUTICS

IF5.5

2024-12-180

PRE

ERRα and ERRγ coordinate expression of genes associated with Alzheimer's disease, inhibiting DKK1 to suppress tau phosphorylation

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2024-09-041

OAAI

Cooperative nuclear action of RNA-binding proteins PSF and G3BP2 to sustain neuronal cell viability is decreased in aging and dementia

IF7.1

2024-08-180

OAAI

Patient-derived castration-resistant prostate cancer model revealed CTBP2 upregulation mediated by OCT1 and androgen receptor

IF3.4

2024-05-023

OAAI

G-protein signaling of oxytocin receptor as a potential target for cabazitaxel-resistant prostate cancer

IF3.8

2024-01-043

OAAI

Identification of DNA damage response-related genes as biomarkers for castration-resistant prostate cancer

SCIENTIFIC REPORTS

IF3.9

2023-11-100

OAAI

Expression and function of estrogen receptors and estrogen-related receptors in the brain and their association with Alzheimer's disease

脑内雌激素受体和雌激素相关受体的表达和功能及其与阿尔茨海默病的关系

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2023-07-0423

OAAI

Identification of small-molecule inhibitors against the interaction of RNA-binding protein PSF and its target RNA for cancer treatment

IF3.8

2023-06-215

OAAI

Role of piRNA biogenesis and its neuronal function in the development of neurodegenerative diseases

FRONTIERS IN AGING NEUROSCIENCE

IF4.5

2023-05-0316

OAAI

Targeting phase separation on enhancers induced by transcription factor complex formations as a new strategy for treating drug-resistant cancers

转录因子复合物形成诱导的增强子靶向相分离作为治疗耐药癌症的新策略

FRONTIERS IN ONCOLOGY

IF3.3

2022-10-039

OAAI

OCT1-target neural gene PFN2 promotes tumor growth in androgen receptor-negative prostate cancer

SCIENTIFIC REPORTS

IF3.9

2022-04-1212

OAAI

Transcriptional and Post-Transcriptional Regulations of Amyloid-β Precursor Protein (APP) mRNA

FRONTIERS IN AGING

IF4.3

2021-08-1111

OAAI

Subtype-specific collaborative transcription factor networks are promoted by OCT4 in the progression of prostate cancer

NATURE COMMUNICATIONS

IF15.7

2021-06-1826

OAAI

Targeting Epigenetic and Posttranscriptional Gene Regulation by PSF Impairs Hormone Therapy-Refractory Cancer Growth

CANCER RESEARCH

IF16.6

2021-05-1111

OA

Recent Discoveries in the Androgen Receptor Pathway in Castration-Resistant Prostate Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2020-10-0834

OAAI

Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factors

COMMUNICATIONS BIOLOGY

IF5.1

2020-07-2336

OAAI

PSF Promotes ER-Positive Breast Cancer Progression via Posttranscriptional Regulation of ESR1 and SCFD2

CANCER RESEARCH

IF16.6

2020-06-0236

OAAI

Ginsenoside Rb1 inhibits vascular calcification as a selective androgen receptor modulator

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2019-09-0129

PREAI

Response to Letter to the Editor: Integrative Genomic Analysis of OCT1 Reveals Coordinated Regulation of Androgen Receptor in Advanced Prostate Cancer

IF3.3

2019-04-030

OAAI